Effects of Yangxue Qingnao Granules on chronic cerebral circulation insufficiency: a randomized, double‐blind, double‐dummy, controlled multicentre trial
Authors:
- Lianming LiaoLLLianming Liao
- Renmin YangRYRenmin Yang
- The Yangxue Qingnao Granule CHRONIC CEREBRAL HYPOPERFUSION STUDY GROUPTGThe Yangxue Qingnao Granule CHRONIC CEREBRAL HYPOPERFUSION STUDY GROUP
- 31 March 2013
- journal article
- research article
- Published by Wiley in Psychogeriatrics
- Vol. 13 (1) , 29-34
Abstract
Background: There is a great deal of interest in traditional Chinese medicine as a treatment for chronic cerebral circulation insufficiency (CCCI). In the present study, we evaluated the efficacy and safety of Yangxue Qingnao Granules (YXQNG) as a monotherapy in patients with CCCI.Methods: From July 2007 to May 2010, 273 patients with CCCI at nine centres in China were randomly assigned to receive either YXQNG with nimodipine placebo (n= 140, 12 g/day) or nimodipine with YXQNG placebo (n= 133, 30 mg/day) for 8 weeks. The primary end points after 8 weeks of treatment were changes from baseline in severity of headache, heavy‐headed feeling, dizziness and sleep disorder.Results: The mean baseline levels of headache, heavy‐headed feeling, dizziness and sleep disorder were comparable between the two groups. Both therapies significantly improved these symptoms after 8 weeks of treatment (P < 0.001). Compared with nimodipine therapy, YXQNG resulted in similar reductions in these symptoms. No adverse effects were observed in the YXQNG group.Conclusions: These data demonstrate that YXQNG as a monotherapy were as effective as nimodipine monotherapy in improving the symptoms of CCCI. It is well‐tolerated and may have an important place in the management of this condition. Whether a combination of these two medicines will increase therapeutic efficacy deserves further clinical investigation.Keywords
This publication has 12 references indexed in Scilit:
- Gypenosides improve cognitive impairment induced by chronic cerebral hypoperfusion in rats by suppressing oxidative stress and astrocytic activationBehavioural Pharmacology, 2011
- Synergistic Memory Impairment Through the Interaction of Chronic Cerebral Hypoperfusion and Amlyloid Toxicity in a Rat ModelStroke, 2011
- Cerebrovascular Hypoperfusion Induces Spatial Memory Impairment, Synaptic Changes, and Amyloid-β Oligomerization in RatsJournal of Alzheimer’s Disease, 2010
- Study on Yangxue Qingnao granule in treating chronic cerebrovascular insufficiencyChinese Journal of Integrative Medicine, 2005
- Vascular dementia from a viewpoint of cerebral blood flow and oxygen metabolismPsychogeriatrics, 2003
- Cognitive impairment and chronic cerebral hypoperfusion: What can be learned from experimental modelsJournal of the Neurological Sciences, 2002
- Alzheimer Disease as a Vascular DisorderStroke, 2002
- Chronic cerebral hypoperfusion in the rat enhances age-related deficits in spatial memoryJournal of Neural Transmission, 2001
- Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in ratsNeuroscience, 1997
- Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical studyActa Neuropathologica, 1994